Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-

Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-

Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Structure
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- structure
CAS No.
2259710-64-8
Chemical Name:
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-
Synonyms
DL5050;Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-
CBNumber:
CB28510426
Molecular Formula:
C23H15Cl2N3O2
Molecular Weight:
436.29
MDL Number:
MOL File:
2259710-64-8.mol
Last updated:2023-03-31 09:12:58
Request For Quotation

Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Properties

Density 1.39±0.1 g/cm3(Predicted)
pka 5.07±0.30(Predicted)

Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth JQD71064 DL5050 2259710-64-8 25mg $886.75 2026-06-04 Buy
Biosynth JQD71064 DL5050 2259710-64-8 50mg $1419.5 2026-06-04 Buy
Biosynth JQD71064 DL5050 2259710-64-8 100mg $1973 2026-06-04 Buy
Axon Medchem Axon3021 DL5050 5mg $154 2026-05-19 Buy
Axon Medchem Axon3021 DL5050 25mg $539 2026-05-19 Buy
Product number Packaging Price Buy
JQD71064 25mg $886.75 Buy
JQD71064 50mg $1419.5 Buy
JQD71064 100mg $1973 Buy
Axon3021 5mg $154 Buy
Axon3021 25mg $539 Buy

Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Chemical Properties, Uses, Production

Description

DL5050 is a Selective Agonist for the Human Constitutive Androstane Receptor. DL5050 demonstrated excellent potency and selectivity for hCAR over hPXR. DL5050 preferentially induced the expression of CYP2B6 (target of hCAR) over CYP3A4 (target of hPXR) on both the mRNA and protein levels. The selective hCAR agonist DL5050 represents a valuable tool molecule to further define the biological functions of hCAR, and may also be used as a new lead in the discovery of hCAR agonists for various therapeutic applications.

Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Preparation Products And Raw materials

Raw materials

Preparation Products

Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Suppliers

Global Suppliers ( 6)
Supplier Tel Email Country ProdList Advantage
Shanghai Beckham Medical Technology Co., Ltd 13816613772 huahero21@sina.com China 2994 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9799 58
BOC Sciences 16314854226; +8616314854226 inquiry@bocsci.com United States 19852 58
Nantong Hi-Future Biotechnology Co., Ltd +86-0513; 18051384581 sales@chemhifuture.com China 3075 58
Supplier Advantage
Shanghai Beckham Medical Technology Co., Ltd 55
Shanghai EFE Biological Technology Co., Ltd. 58
BOC Sciences 58
Nantong Hi-Future Biotechnology Co., Ltd 58
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- DL5050 2259710-64-8